Correlation Between Maat Pharma and Memscap Regpt

Can any of the company-specific risk be diversified away by investing in both Maat Pharma and Memscap Regpt at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Maat Pharma and Memscap Regpt into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Maat Pharma SA and Memscap Regpt, you can compare the effects of market volatilities on Maat Pharma and Memscap Regpt and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Maat Pharma with a short position of Memscap Regpt. Check out your portfolio center. Please also check ongoing floating volatility patterns of Maat Pharma and Memscap Regpt.

Diversification Opportunities for Maat Pharma and Memscap Regpt

0.63

Correlation Coefficient

Maat Pharma  Memscap Regpt

Poor diversification

The 3 months correlation between Maat and Memscap is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Maat Pharma SA and Memscap Regpt in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Memscap Regpt and Maat Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Maat Pharma SA are associated (or correlated) with Memscap Regpt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Memscap Regpt has no effect on the direction of Maat Pharma i.e., Maat Pharma and Memscap Regpt go up and down completely randomly.

Pair Corralation between Maat Pharma and Memscap Regpt

Assuming the 90 days trading horizon Maat Pharma SA is expected to under-perform the Memscap Regpt. But the stock apears to be less risky and, when comparing its historical volatility, Maat Pharma SA is 1.6 times less risky than Memscap Regpt. The stock trades about -0.09 of its potential returns per unit of risk. The Memscap Regpt is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  306.00  in Memscap Regpt on November 29, 2024 and sell it today you would earn a total of  44.00  from holding Memscap Regpt or generate 14.38% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.39%
Values	Daily Returns

Maat Pharma SA  vs.  Memscap Regpt

Maat Pharma SA

Risk-Adjusted Performance

Very Weak

Over the last 90 days Maat Pharma SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Memscap Regpt

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Memscap Regpt are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Memscap Regpt sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Maat Pharma and Memscap Regpt

The main advantage of trading using opposite Maat Pharma and Memscap Regpt positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Maat Pharma position performs unexpectedly, Memscap Regpt can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Memscap Regpt will offset losses from the drop in Memscap Regpt's long position.

The idea behind Maat Pharma SA and Memscap Regpt pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.